The Debt to Equity Ratio is a company’s total liabilities divided by its shareholder equity. It's the degree to which a company is financing its operations through debt v/s wholly owned funds

Higher than Industry Debt to Equity Ratio

Current ratio measures a company’s ability to pay short-term obligations. Higher is better

Lower than Industry Current Ratio

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Lower than Industry Revenue Growth

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Decreasing Market Share

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Higher than Industry Net Income

The EBITDA margin is the percent of revenue that the company retains after incurring all the direct and operational costs of the business

Lower than Industry EBITDA Margin

The net profit margin is net income or profit generated as a percentage of revenue and illustrates how much of each rupee in revenue translates to profit

Lower than Industry Net Profit Margin

Y-o-y growth in the total revenue represents increased potential for the company to increase their market share.Total revenue for the current quarter is compared with the same quarter of previous year to reduce the effects of seasonality

Increasing Total Revenue

Increasing EBITDA margin indicates increased profit efficiency without taking into account financial, accounting or tax implications

Increasing EBITDA Margin

Increasing Net profit margins indicates the increasing profit to the shareholders with each unit of revenue

Decreasing Net Profit Margin

Hasn't faired well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Average profitability - not good, not bad

Profitability

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

The stock has a moderate number of red flags

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Strides Arcolab Limited has submitted to the Exchange a copy of investor presentation issued by the Company on the merger of Shasun Pharmaceuticals in Strides Arcolab.

Investor Presentation

Strides Pharma Science is a vertically integrated global pharmaceutical company engaged in the development and manufacturing of active pharmaceutical ingredients and formulations, as well as biotech

Financial Year	FY 2014	FY 2015	FY 2016	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	TTM
Total Revenue	4,623.48	2,099.43	2,961.59	3,097.80	3,534.85	2,545.66	2,909.44	3,518.84	3,258.10	3,791.96
Raw Materials	720.40	574.64	1,612.38	1,432.25	1,286.65	1,189.20	1,167.29	1,686.50	1,407.04	3,682.30
Power & Fuel Cost	18.56	16.02	77.18	33.87	51.33	54.39	64.49	64.58	71.54
Employee Cost	157.18	172.06	357.70	419.16	434.05	329.44	442.56	550.15	646.91
Selling & Administrative Expenses	92.15	144.68	323.35	339.47	409.34	276.20	338.51	473.78	577.98
Operating & Other expenses	579.96	88.55	154.11	54.45	313.14	196.74	525.25	98.10	797.39
EBITDA	3,055.23	1,103.48	436.87	818.60	1,040.34	499.69	371.34	645.73	-242.76	109.66
Depreciation/Amortization	56.48	64.03	131.25	126.15	154.04	117.39	173.70	206.29	233.01	243.00
PBIT	2,998.75	1,039.45	305.62	692.45	886.30	382.30	197.64	439.44	-475.77	-133.34
Interest & Other Items	108.88	47.44	168.17	183.10	196.24	79.29	155.72	150.07	176.74	230.10
PBT	2,889.87	992.01	137.45	509.35	690.06	303.01	41.92	289.37	-652.51	-363.44
Taxes & Other Items	1,123.12	147.01	28.92	109.60	25.55	-21.60	5.53	20.94	-192.30	-199.57
Net Income	1,766.75	845.00	108.53	399.75	664.51	324.61	36.39	268.43	-460.21	-163.87
EPS	288.90	137.23	14.10	43.28	71.89	35.67	4.06	29.95	-51.29	-18.25
DPS	488.74	104.52	4.84	4.36	1.94	3.00	14.00	2.50	0.00	0.00
Payout ratio	1.69	0.76	0.34	0.10	0.03	0.08	3.45	0.08	0.00	0.00

Strides Pharma Science Ltd

Strides Pharma Science Ltd

Scorecard

Financial Statements

What is an income statement?

Income Statement
Industry refers to the sub-sector this company belongs to.

Lower than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Decreasing Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Company Updates

Strides Pharma Science Ltd

Scorecard

Financial Statements

What is an income statement?

Income StatementIndustry refers to the sub-sector this company belongs to.

Lower than Industry Revenue GrowthA higher-than-industry revenue growth represents increased potential for the company to increase their market share

Decreasing Market ShareMarket share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Company Updates

Income Statement
Industry refers to the sub-sector this company belongs to.

Lower than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Decreasing Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors